Innovating Technology Solutions for Residents in Support Housing Communities w SUD Through Community-Engaged Research
Launched by OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. · May 30, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a technology-based solution can help residents living in supportive housing who may be dealing with substance use issues. The main goal is to see if this solution, which will be developed with input from the community, is easy to use and can help improve residents' understanding of important topics related to their stability and well-being. All participants will engage with this technology for two weeks, which may include videos and rewards for completing the content.
To be eligible for the trial, participants must be at least 18 years old and either a current or former resident of a supportive housing community who has experienced substance use challenges. Staff members from partner agencies can also participate if they meet the age requirement. This study is not yet recruiting participants, but it aims to gather valuable information on how technology can support individuals in these housing communities.
Gender
ALL
Eligibility criteria
- Residents:
- • 1. 18 and older;
- • 2. past or current resident in supportive housing community;
- • 3. past or current elevated substance use
- Staff:
- • 1. 18 or older;
- • 2. staff at partner agency
About Oregon Research Behavioral Intervention Strategies, Inc.
Oregon Research Behavioral Intervention Strategies, Inc. is a dedicated clinical trial sponsor focused on advancing innovative behavioral health solutions. With a commitment to improving patient outcomes, the organization specializes in designing, implementing, and evaluating evidence-based interventions that address a range of psychological and behavioral health challenges. Leveraging a multidisciplinary approach, Oregon Research aims to foster collaboration among researchers, healthcare providers, and community stakeholders, ensuring that their studies not only meet rigorous scientific standards but also translate effectively into real-world applications. Through its comprehensive research initiatives, the organization strives to contribute to the enhancement of mental health care and the overall well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Springfield, Oregon, United States
Patients applied
Trial Officials
David R Smith, PhD
Principal Investigator
Oregon Research Behavioral Intervention Strategies, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported